Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.

Metabolism: clinical and experimental

Volumn 52, Issue 1, 2003, Pages 116-121

  González, Ana Inés ^a   Schreier, Laura ^a   Elbert, Alicia ^a   Berg, Gabriela ^a   Beresan, Hugo ^a   López, Graciela ^a   Wikinski, Regina ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; APOPROTEIN; INSULIN; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE;

ADULT; ARTICLE; BLOOD; CLINICAL TRIAL; ENZYMOLOGY; FEMALE; HUMAN; LIVER; LIVER FUNCTION TEST; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; RENAL REPLACEMENT THERAPY;

ADULT; APOPROTEINS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LIPASE; LIPIDS; LIPOPROTEINS; LIPOPROTEINS, LDL; LIVER; LIVER FUNCTION TESTS; MALE; RENAL DIALYSIS; TRIGLYCERIDES;

EID: 0037271733     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2003.50018     Document Type: Article

References (0)